PZU’s net income for the first quarter went beyond estimates, coming in at 1.25 billion zloty.
This is a notable 9% increase year on year, from the estimated 1.21 billion zloty.
The total insurance sales for the same period hit 7.01 billion zloty.
Compared to the same quarter in the previous year, this demonstrated an impressive growth of 9.6%.
The operating profit saw a hike and was recorded at 3.77 billion zloty, marking a 10% growth year on year.
The company received 6 buy ratings, 5 hold ratings, and 1 sell rating.
A look at Powszechny Zaklad Ubezpieczen Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Long-Term Outlook for Powszechny Zaklad Ubezpieczen
In analyzing Powszechny Zaklad Ubezpieczen SA’s long-term outlook, Smartkarma’s Smart Scores provide valuable insights. With a strong Growth score of 5, the company is poised for expansion and development in its property and casualty insurance offerings. Additionally, a Momentum score of 5 suggests that Powszechny Zaklad is experiencing positive market momentum, indicating potential for sustained growth in the future.
Although Value and Resilience scores come in at 3, showing steady performance in these aspects, a remarkable Dividend score of 4 showcases the company’s ability to provide attractive returns to its shareholders. Overall, Powszechny Zaklad Ubezpieczen demonstrates promising prospects in the insurance sector, offering a diversified range of non-life insurance products with a dedicated division for life insurance services.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
